Colorcon acquires French excipient firm NP Pharm
Colorcon Inc has expanded its excipient product offerings with the acquisition of NP Pharm
Colorcon Inc has expanded its excipient product offerings in the pharmaceutical and nutritional markets with the acquisition of excipient company, NP Pharm, a division of Ethypharm.
The company says the addition of NP Pharm SUGLETS sugar spheres complements Colorcon's SureSpheres sugar spheres product line and barrier membrane systems for multiparticulates. Colorcon will now have two production facilities for sugar spheres offering critical business continuity planning for their customer base.
ETHISPHERES microcrystalline cellulose pellets, NPTAB neutral pellets for direct compression, and other excipient products are also added to the Colorcon product portfolio as a result of this acquisition.
The headquarters and main production facilities of NP Pharm, located in Bazainville, France, will become an integral part of the Colorcon network of manufacturing sites.
Ethypharm, meanwhile, is dedicated to the development of technologies designed to offer improved drug efficacy, administration, compliance, and reduced side-effects. Newly appointed chairman and ceo of Ethypharm, Hugues Lecat said: ‘We are delighted to see NP Pharm join Colorcon, Inc. The new shareholder will permit NP Pharm to reinforce its development and growth projects. This divestiture will enable us to go on investing in the growth of Ethypharm, in line with our strategy. Ethypharm will continue to invest in its R&D sites, notably that of Grand Quevilly, France, our most recent state-of-the-art manufacturing plant, in which we have invested over E15 m over the last two years.’
